SCHEMBL5841555

SCHEMBL5841555

O=c1c(Cl)c(Cl)cnn1-c1ccc(Cl)cc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.50
RAB9A P51151 7/20 0.50
HTT P42858 7/20 0.50
ALDH1A1 P00352 7/20 0.50
NPC1 O15118 5/20 0.50
MAPT P10636 5/20 0.50
PAX8 Q06710 3/20 0.50
S1PR4 O95977 3/20 0.50
S1PR1 P21453 3/20 0.50
MITF O75030 3/20 0.50
XBP1 P17861 3/20 0.50
THRB P10828 1/20 0.50
KMT2A Q03164 2/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
NPSR1 Q6W5P4 6/20 0.42
PKM P14618 3/20 0.42
LMNA P02545 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9665772 0.88 RAB9A (0.50) SMN1; SMN2RAB9AHTTALDH1A1NPC1
SCHEMBL13219469 0.86 ALDH1A1 (0.54) SMN1; SMN2RAB9AHTTALDH1A1NPC1
SCHEMBL9665494 0.85 SMN1; SMN2 (0.41) SMN1; SMN2RAB9AHTTALDH1A1NPC1
SCHEMBL11724179 0.83 HTT (0.54) SMN1; SMN2RAB9AHTTALDH1A1NPC1
SCHEMBL11726226 0.82 RAB9A (0.54) SMN1; SMN2RAB9AHTTALDH1A1NPC1
SCHEMBL19000700 0.81 RAB9A (0.61) SMN1; SMN2RAB9AHTTALDH1A1NPC1
SCHEMBL11733824 0.79 RAB9A (0.54) SMN1; SMN2RAB9AHTTALDH1A1NPC1
SCHEMBL8012346 0.78 HSD11B1 (0.43) ALDH1A1NPSR1LMNAALOX12MAPK14
SCHEMBL6955767 0.78 ALDH1A1 (0.45) SMN1; SMN2RAB9AHTTALDH1A1NPC1
SCHEMBL5843735 0.78 HTT (0.45) SMN1; SMN2RAB9AHTTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7012041-B2 Phenylpyridazinones BAYER AG (DE) 2006-03-14 US disclosed
EP-0832072-B1 PHENYLPYRIDAZINONES BAYER CROPSCIENCE AG (DE) 2003-09-24 EP disclosed
US-20030119673-A1 Phenylpyridazinones LINKER KARL-HEINZ (DE) 2003-06-26 US disclosed
US-6551963-B1 For controlling unwanted vegetation BAYER AKTIENGESELLSCHAFT (DE) 2003-04-22 US disclosed
EP-0832072-A1 PHENYLPYRIDAZINONES BAYER AG (DE) 1998-04-01 EP disclosed
WO-1996039392-A1 PHENYLPYRIDAZINONES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-12 WO disclosed
EP-0210647-B1 PYRIDAZINONE DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND INSECTICIDAL COMPOSITIONS NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-10-28 EP disclosed
US-4910201-A With an ether substituted in position 5 NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1990-03-20 US disclosed
EP-0210647-A2 Pyridazinone derivatives, process for preparation thereof and insecticidal compositions NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1987-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030119673-A1 Phenylpyridazinones CYP2D6, CYP1A1, CYP1B1 SMN1; SMN2 4323/4885RAB9A 2247/4885HTT 2267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.